Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04242784 · ClinicalTrials.gov registry record
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 21,646
- Enrollment target
NCT04242784: Completed study, sponsored by Duke University.
NCT04242784 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 21,646 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04242784 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 21,646 participants
- Enrollment target
Study Summary
The purpose of this program is to develop a regional integrated stroke system that identifies, classifies, and treats patients with acute ischemic stroke more rapidly and effectively with reperfusion therapy.
Primary Outcome
The time frame starting from the earliest time that the patient is documented as arriving to the hospital to the beginning time of the administration of the drug (TPA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,646 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2021-04-30 |
What the finished NCT04242784 record still lists
NCT04242784 is an observational study that tracks outcomes without assigning an intervention. Its 21,646 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04242784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04242784 about?
NCT04242784 is a clinical study titled "IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care". The purpose of this program is to develop a regional integrated stroke system that identifies, classifies, and treats patients with acute ischemic stroke more rapidly and effectively with reperfusion therapy.
What is the current status of trial NCT04242784?
This trial is currently completed. The enrollment target is 21,646 participants. The study started on 2019-01-01. Estimated completion is 2021-04-30.
Who is sponsoring clinical trial NCT04242784?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI